Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.220
+0.040 (22.22%)
Dec 5, 2025, 3:58 PM EST
-67.65%
Market Cap 16.85M
Revenue (ttm) 10.88K
Net Income (ttm) -4.01M
Shares Out 76.57M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,000
Average Volume 9,342
Open 0.200
Previous Close 0.180
Day's Range 0.200 - 0.220
52-Week Range 0.125 - 1.250
Beta -0.03
RSI 31.42
Earnings Date Nov 28, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.